Literature DB >> 21365291

Cranial Ewing's sarcoma in children.

Maria Moschovi1, George A Alexiou, Natalia Tourkantoni, Mirsini-Ersi Balafouta, Christos Antypas, Maria Tsiotra, George Sfakianos, Neofytos Prodromou.   

Abstract

Ewing's sarcoma is a highly malignant neoplasm of bones which accounts for the 10% of primary bone malignancies. Primary Ewing's sarcoma of skull vault is very rare and constitutes 1-6% of all Ewing's sarcomas. We present a case of a primary and a radiation-induced skull Ewing's sarcoma. The symptoms, neuroimaging findings and the treatment for these cases are reviewed. Both children were operated with favorable outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365291     DOI: 10.1007/s10072-011-0509-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

Review 1.  Ewing's family of tumors involving structures related to the central nervous system: a review.

Authors:  M G Hadfield; M M Quezado; R L Williams; V Y Luo
Journal:  Pediatr Dev Pathol       Date:  2000 May-Jun

Review 2.  Primary Ewing's sarcoma of the cranium.

Authors:  K I Desai; T D Nadkarni; A Goel; D P Muzumdar; K N Naresh; C N Nair
Journal:  Neurosurgery       Date:  2000-01       Impact factor: 4.654

3.  Primary Ewing's sarcoma of the sphenoid bone with unusual imaging features: a case report.

Authors:  Ashwani Sharma; Ajay Garg; Nalini K Mishra; Shailesh B Gaikwad; Mehar C Sharma; Vipul Gupta; Ashish Suri
Journal:  Clin Neurol Neurosurg       Date:  2004-12-13       Impact factor: 1.876

4.  Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.

Authors:  Maria Moschovi; Georgios Trimis; Kalliopi Stefanaki; John Anastasopoulos; Vassiliki Syriopoulou; Eleutheria Koultouki; Fotini Tzortzatou-Stathopoulou
Journal:  J Surg Oncol       Date:  2005-03-15       Impact factor: 3.454

5.  Classics in oncology. Diffuse endothelioma of bone. James Ewing. Proceedings of the New York Pathological Society, 1921.

Authors:  J Ewing
Journal:  CA Cancer J Clin       Date:  1972 Mar-Apr       Impact factor: 508.702

6.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Authors:  Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 7.  Neurooncology of familial cancer syndromes.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  J Child Neurol       Date:  2009-12       Impact factor: 1.987

8.  Second malignancies in patients treated for childhood acute lymphoblastic leukemia.

Authors:  V M Kimball Dalton; R D Gelber; F Li; M J Donnelly; N J Tarbell; S E Sallan
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

9.  Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital.

Authors:  A W Walter; M L Hancock; C H Pui; M M Hudson; J S Ochs; G K Rivera; C B Pratt; J M Boyett; L E Kun
Journal:  J Clin Oncol       Date:  1998-12       Impact factor: 44.544

10.  Meningioma following high-dose radiation therapy. Case report and review of the literature.

Authors:  M Domenicucci; M Artico; F Nucci; M Salvati; L Ferrante
Journal:  Clin Neurol Neurosurg       Date:  1990       Impact factor: 1.876

View more
  2 in total

1.  Diffusion-weighted imaging of skull lesions.

Authors:  Daniel T Ginat; Rajiv Mangla; Gabrielle Yeaney; Sven Ekholm
Journal:  J Neurol Surg B Skull Base       Date:  2014-03-12

2.  Primary pericranial Ewing's sarcoma on the temporal bone: A case report.

Authors:  Hiroto Kawano; Naoki Nitta; Mitsuaki Ishida; Tadateru Fukami; Kazuhiko Nozaki
Journal:  Surg Neurol Int       Date:  2016-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.